Status:
COMPLETED
Cognitive and Speech Disorders in Children With Congenital Heart Defects
Lead Sponsor:
Kemerovo State Medical University
Conditions:
Cognition Disorder
Eligibility:
All Genders
5-7 years
Brief Summary
The study is aimed to found out expressive speech disorders as a sign of neurocognitive development delay in children with congenital heart defects before and after surgery
Detailed Description
The study will investigate the influence of congenital heart disease, operation and other health factors on neurocognitive and speech status of 5-7 years old children
Eligibility Criteria
Inclusion
- children with congenital heart disease that required total correction using cardiopulmonary bypass
Exclusion
- patients with heart disease requiring palliative or endovascular correction, as well as children with chromosomal and genetic diseases (determined by karyotyping)
Key Trial Info
Start Date :
March 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 1 2024
Estimated Enrollment :
217 Patients enrolled
Trial Details
Trial ID
NCT06565299
Start Date
March 1 2019
End Date
August 1 2024
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aleksandra Aeksandrovna Rumiantseva
Kemerovo, Kemerovo Oblast, Russia, 650066